Genomma Lab Internacional, S.A.B. de C.V. (GNMLF)
GNMLF Stock Price Chart
Explore Genomma Lab Internacional, S.A.B. de C.V. interactive price chart. Choose custom timeframes to analyze GNMLF price movements and trends.
GNMLF Company Profile
Discover essential business fundamentals and corporate details for Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
4 May 2012
Employees
1.61K
Website
https://www.genommalab.comCEO
Juan Marco Sparvieri
Description
Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, engages in the development, marketing, and sale of over-the-counter pharmaceutical and personal care products in Mexico and internationally. It provides skin care, health and wellness, hair care, pain relief, cough and cold, gastro, sexual health, antiperspirant deodorant, hand sanitizer, isotonic deink, and razor products, as well as analgesics, antifungals, and hemorrhoids. The company offers its products under the Cicatricure, Asepxia, Teatrical, Goicoechea, Sistema GB, Medicasp, Tío Nacho, Vanart, Novamil, Ultra Bengue, X-Ray, Tafirol, Alliviax, Bufferin, Next, XL-3, Genoprazol, QG5, Kaopectate, Proctan, Nikzon, Unesia, Silka Medic, lagicam, Suerox, Groomen, DiabetTX, and other brands. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.
GNMLF Financial Timeline
Browse a chronological timeline of Genomma Lab Internacional, S.A.B. de C.V. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Apr 2026
Upcoming earnings on 24 Feb 2026
Upcoming earnings on 22 Oct 2025
Earnings released on 23 Jul 2025
EPS came in at $0.36 surpassing the estimated $0.03 by +1.18K%, while revenue for the quarter reached $4.68B , beating expectations by +1.76K%.
Dividend declared on 23 Jun 2025
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 1 Jul 2025.
Earnings released on 30 Apr 2025
EPS came in at $0.51 surpassing the estimated $0.02 by +2.37K%, while revenue for the quarter reached $4.41B , missing expectations by -5.08%.
Dividend declared on 6 Mar 2025
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 14 Mar 2025.
Earnings released on 27 Feb 2025
EPS came in at $0.48 surpassing the estimated $0.03 by +1.63K%, while revenue for the quarter reached $4.67B , missing expectations by -1.56%.
Dividend declared on 9 Dec 2024
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 18 Dec 2024.
Earnings released on 23 Oct 2024
EPS came in at $0.04 surpassing the estimated $0.03 by +29.33%, while revenue for the quarter reached $5.09B , beating expectations by +2.05K%.
Dividend declared on 6 Sept 2024
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 17 Sept 2024.
Earnings released on 24 Jul 2024
EPS came in at $0.04 surpassing the estimated $0.02 by +59.08%, while revenue for the quarter reached $253.60M , beating expectations by +5.52%.
Dividend declared on 13 Jun 2024
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 21 Jun 2024.
Earnings released on 24 Apr 2024
EPS came in at $0.02 surpassing the estimated $0.02 by +10.15%, while revenue for the quarter reached $253.27M , beating expectations by +7.25%.
Dividend declared on 21 Mar 2024
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 25 Mar 2024.
Earnings released on 22 Feb 2024
EPS came in at -$0.01 falling short of the estimated $0.01 by -160.80%, while revenue for the quarter reached $207.52M , missing expectations by -7.06%.
Dividend declared on 13 Dec 2023
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 27 Dec 2023.
Earnings released on 29 Sept 2023
EPS came in at $0.02 falling short of the estimated $0.02 by -7.74%, while revenue for the quarter reached $252.04M , beating expectations by +1.50%.
Dividend declared on 19 Sept 2023
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 29 Sept 2023.
Earnings released on 29 Jun 2023
EPS came in at $0.03 surpassing the estimated $0.02 by +10.47%, while revenue for the quarter reached $254.98M , missing expectations by -1.34%.
Dividend declared on 29 May 2023
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend was paid on 7 Jun 2023.
Earnings released on 30 Mar 2023
EPS came in at $0.02 falling short of the estimated $0.02 by -1.24%, while revenue for the quarter reached $231.64M , missing expectations by -0.53%.
Earnings released on 22 Feb 2023
EPS came in at $0.27 falling short of the estimated $0.39 by -30.77%, while revenue for the quarter reached $213.85M , missing expectations by -1.97%.
Earnings released on 26 Oct 2022
EPS came in at $0.40 falling short of the estimated $0.43 by -6.98%, while revenue for the quarter reached $215.72M , missing expectations by -1.52%.
Dividend declared on 26 Oct 2022
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 11 Nov 2022.
Earnings released on 27 Jul 2022
EPS came in at $0.40 falling short of the estimated $0.43 by -6.98%, while revenue for the quarter reached $214.71M , beating expectations by +1.86%.
Dividend declared on 30 May 2022
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 8 Jun 2022.
Earnings released on 27 Apr 2022
EPS came in at $0.34 falling short of the estimated $0.45 by -24.44%, while revenue for the quarter reached $201.90M , beating expectations by +0.39%.
Earnings released on 23 Feb 2022
EPS came in at $0.36 falling short of the estimated $0.41 by -12.20%, while revenue for the quarter reached $199.16M , beating expectations by +8.21%.
Dividend declared on 26 Nov 2021
A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 10 Dec 2021.
Dividend declared on 25 Nov 2021
A dividend of $0.04 per share was announced, adjusted to $0.04. The dividend was paid on 3 Dec 2021.
Earnings released on 27 Oct 2021
EPS came in at $0.39 falling short of the estimated $0.42 by -7.14%, while revenue for the quarter reached $192.93M .
Earnings released on 28 Jul 2021
EPS came in at $0.38 falling short of the estimated $0.40 by -5.00%, while revenue for the quarter reached $194.14M .
Earnings released on 28 Apr 2021
EPS came in at $0.32 falling short of the estimated $0.37 by -13.51%, while revenue for the quarter reached $173.39M .
Earnings released on 24 Feb 2021
EPS came in at $0.33 surpassing the estimated $0.32 by +3.13%.
Earnings released on 21 Oct 2020
EPS came in at $0.40 surpassing the estimated $0.33 by +21.21%.
GNMLF Stock Performance
Access detailed GNMLF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.